Pharma Base India Private Limited, a active private limited company, was established on 14 July 1998 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24200MH1998PTC115774. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹39.60 Cr.
It upholds a compliant status. Employing 3 professional, Its leadership includes Kishor Olivier Parekh (Director), Dhananjay Thakorbhai Desai (Director). Past directors included Pravinchandra Thakorlal Mehta, Manoj Gunvantray Oza, Kishor Olivier Parekh. It holds no open charges and ₹10.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C-1, Kalpita Enclave Sahar Road, Andheri (East), Mumbai, Maharashtra, 400069.
U24200MH1998PTC115774
115774
14 July 1998
₹40.00 Cr
₹39.60 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Pharma Base India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kishor Olivier Parekh | Director | 20 May 2019 | Current |
| Dhananjay Thakorbhai Desai | Director | 01 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Oct 2020 | Past |
| Pramod Abcsdd | Alternate Director | 28 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2019 | Past |
| Pramod Abcsdd | Director | 28 Apr 2019 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pharma Base India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 701.8% increase. The company also saw a substantial improvement in profitability, with a 2194.78% increase in profit. The company's net worth Soared by an impressive increase of 20.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Pharma Base India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹100,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Apr 2008 | Icici Bank Limited | ₹10.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Pharma Base India has a workforce of 3 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pharma Base India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Base India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Pharma Base India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Pharma Base India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
The activity Dhwani Dinesh Punamiya was appointed as a Company Secretary was appointed as a Company Secretary on 03 May 2024 & has been associated with this company since 1 year 6 months . was completed.
Progress on Dhananjay Thakorbhai Desai was appointed as a Director was appointed as a Director on 01 Aug 2020 & has been associated with this company since 5 years 4 months . was documented.
Progress on Kishor Olivier Parekh was appointed as a Director was appointed as a Director on 20 May 2019 & has been associated with this company since 6 years 6 months . was documented.
The activity A charge registered on 22 Apr 2008 via Charge ID 10135704 with Icici Bank Limited was fully satisfied on 17 Apr 2015. was completed.
The CIN of Pharma Base India Private Limited is U24200MH1998PTC115774.
Pharma Base India Private Limited is headquartered at C-1, Kalpita Enclave Sahar Road, Andheri (East), Mumbai, Maharashtra, 400069.
Pharma Base India Private Limited was incorporated on 14 July 1998.
The current directors of Pharma Base India Private Limited are
The primary industry of Pharma Base India Private Limited is Manufacturing.
Pharma Base India Private Limited is unlisted.
The authorized capital of Pharma Base India Private Limited is ₹40.00 Cr, and the paid-up capital is ₹39.60 Cr.
The compliance status of Pharma Base India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX